Nkarta, Inc. (NKTX) vs PepGen Inc. (PEPG)

A side-by-side comparison of Nkarta, Inc. and PepGen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NKTX

Nkarta, Inc.

$166M

$2.32HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT

PEPG

PepGen Inc.

$161M

$2.33HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — NKTX vs PEPG

growth of $100 · dividends reinvested · last 4y

NKTX -83.5% (-36.2%/yr)PEPG -81.7% (-34.6%/yr)PEPG compounded faster over this window

NKTX PEPG

NKTX vs PEPG: by the numbers

•NKTX is the larger company ($166M vs $161M market cap).

Metrics side by side

Valuation

Metric	NKTX	PEPG
P/B ratio	0.67	1.35

Profitability

Metric	NKTX	PEPG
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-47.36%	-60.19%
ROIC	-42.11%	-57.59%

Growth (annualized)

Metric	NKTX	PEPG
Total return CAGR (5Y)	-37.28%	N/A

Go deeper

Full NKTX analysis Full PEPG analysis Interactive comparison tool

Dig into the metrics

Nkarta ROE PepGen ROE Nkarta operating margin PepGen operating margin Nkarta revenue growth PepGen revenue growth Nkarta free cash flow PepGen free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.